Exactech Marks 30 Year Anniversary with Introduction of New Clinical Solutions for Improved Patient Outcomes at AAOS 2015 Ann...
March 24 2015 - 10:03AM
Business Wire
Company Unveils Next Generation of
ExactechGPS® and Cementless Option for Optetrak® Logic Knee,
Launches Alteon® Brand of Hip Stems featuring Tapered Wedge Femoral
Stem, Celebrates 10 Year Anniversary of Equinoxe® Shoulder
System
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, shoulder and spine,
marks its 30 year anniversary of developing and producing bone and
joint restoration products including hip, knee, shoulder and spine
surgery, by presenting a strong line-up of innovations at the
company’s educational exhibit, booth #2025, at the American Academy
of Orthopedic Surgeons (AAOS) 2015 Annual Meeting, March 24-27 in
Las Vegas, NV.
EXACTECH KNEE
Offering advanced approaches in total knee arthroplasty,
surgeons can have every confidence in the clinically recognized
Exactech Knee system given its long-term clinical results1 and
solutions for reproducible outcomes, case after case. Be among the
first to see the most recent additions to the Exactech Knee product
family:
- The next generation of ExactechGPS®
Guided Personalized Surgery merges sophisticated technology with
innovative instrumentation for a real-time, patient-specific
solution in total knee arthroplasty. Customized for surgeon
preferences, ExactechGPS offers personalized workflow options for
reproducibility and efficiency and is surgeon-controlled through a
compact, stand-alone system that is designed to integrate into any
surgical environment.
- A new cementless fixation solution for
total knee arthroplasty, Optetrak Logic® Porous femoral component
strikes the optimal balance between material strength, pore size
and porosity. In an ovine study*, the system’s proprietary material
comprised of a unique 3-D structural lattice of irregular shaped
particles demonstrated higher bone in-growth, greater shear
strength and greater fixation than traditional porous-beaded
coating.1
EXACTECH HIP
The Exactech Hip portfolio expands its scope of solutions to
include:
- The introduction of the Alteon® Tapered
Wedge Femoral Stem. This next generation, single-taper, wedge-style
femoral stem incorporates specific design features to achieve
immediate axial and rotational mechanical stability between the
medial and lateral cortices of the femoral canal.
- The continued rollout of the Alteon
Neck Preserving Femoral Stem which was developed for primary
femoral solutions. Unlike traditional stems, this product is a
conservative treatment option designed for maintaining the maximum
amount of femoral bone.2
- InteGrip® which is a three-dimensional,
porous ingrowth material that was developed for acetabular cups in
revision and complex primary procedures.
EXACTECH SHOULDER
The Equinoxe® Shoulder System celebrates 10 years of engineering
solutions to solve clinical challenges and improve patient outcomes
with the introduction of two additions to its wide range of glenoid
options.
- The Posterior Augment Cage Glenoid is
designed to provide immediate fixation for anatomic TSA.
- The Superior/Posterior Augment
Baseplate is a new augment designed to correct for superior and
posterior wear during challenging reverse procedures.
EXACTECH POWER EQUIPMENT
Implant removal solutions on display in Exactech’s technical
exhibit include the AcuDriver® Automated Osteotome System, an
air-driven impact handpiece with precision osteotomes in various
sizes for use in revision surgeries.
EXACTECH SPACER
Exactech’s InterSpace® hip, knee and shoulder spacers are used
in two-stage infected revision procedures and provide orthopaedic
surgeons with the only preformed spacer on the market with a
documented clinical history. Learn more about the unique and
convenient way to treat this difficult problem and the data behind
the only preformed spacer technology with 19 years of clinical
experience.
EXACTECH BIOLOGICS
Exactech recognizes the growing importance of biologic solutions
for orthopaedics and is proud to feature Optecure®, an
engineered bone graft for reconstruction of the spine, pelvis and
extremities. Its room temperature convenience facilitates rapid
mixing with buffer solution or blood. Optecure and Optecure+ccc can
be used with autologus bone and bone marrow.
Participate in Live Demos
Each day from 12:30 to 1:30pm, Gérard Giordano, MD and Bernard
Stulberg, MD demonstrate the next generation of ExactechGPS®.
Clinicians may also gain first-hand experience with the
AcuDriver® Automated Osteotome System and get an up-close look at
our instrumentation in the surgical skills labs.
Enhance your AAOS Experience
At a time when so much is changing in our industry, surgeons
might find it refreshing to know that Exactech is holding strong to
its focus on surgeons’ clinical needs and their patients’ outcomes.
Clinicians are invited to meet our leadership, to ask questions of
our product developers and to exchange ideas with their clinician
peers. Exactech’s free Academy App helps attendees make the most of
their time at the AAOS Annual Meeting with a schedule of surgeon
experts’ availability, an overview of Exactech technologies and
maps of the Venetian/Sands EXPO exhibit hall. The app can be
installed on any mobile device from Exactech’s webpage
http://www.exac.com/medical-professionals/academy.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, as well as more than 30 markets
in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
References
1. Data on file at Exactech.
2. Data on file at Exactech.
*Laboratory and/or animal study tests are not necessarily
predictive of clinical outcomes.
Exactech, Inc.Investor contactsJody Phillips,
352-377-1140Executive Vice President of Finance & Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888E-mail: EXAC@hawkassociates.comorMedia contactPriscilla
Bennett, 352-377-1140Vice President, Corporate & Marketing
Communication
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Sep 2023 to Sep 2024